Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
7.60 x 5 9.40 x 3
Pre-market by (Cboe BZX)
7.68 +0.17 (+2.26%) 04/21/25 [NASDAQ]
7.60 x 5 9.40 x 3
Pre-market 7.71 +0.03 (+0.39%) 04:47 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.25
Day High
7.70
Open 7.39
Previous Close 7.51 7.51
Volume 6,988,500 6,988,500
Avg Vol 3,701,155 3,701,155
Stochastic %K 32.11% 32.11%
Weighted Alpha -75.05 -75.05
5-Day Change -0.33 (-4.12%) -0.33 (-4.12%)
52-Week Range 6.78 - 29.37 6.78 - 29.37
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 939,279
  • Shares Outstanding, K 122,302
  • Annual Sales, $ 610,790 K
  • Annual Income, $ -182,630 K
  • EBIT $ -195 M
  • EBITDA $ -151 M
  • 60-Month Beta 2.01
  • Price/Sales 1.50
  • Price/Cash Flow N/A
  • Price/Book 1.38

Options Overview Details

View History
  • Implied Volatility 122.59% ( +18.23%)
  • Historical Volatility 95.00%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 122.59% on 04/21/25
  • IV Low 54.38% on 08/23/24
  • Put/Call Vol Ratio 0.59
  • Today's Volume 248
  • Volume Avg (30-Day) 215
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 8,348
  • Open Int (30-Day) 7,868

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.45
  • Number of Estimates 8
  • High Estimate -0.31
  • Low Estimate -0.65
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.78 +13.27%
on 04/07/25
Period Open: 10.39
10.60 -27.55%
on 03/24/25
-2.71 (-26.08%)
since 03/21/25
3-Month
6.78 +13.27%
on 04/07/25
Period Open: 16.16
16.75 -54.15%
on 01/22/25
-8.48 (-52.48%)
since 01/21/25
52-Week
6.78 +13.27%
on 04/07/25
Period Open: 27.94
29.37 -73.85%
on 04/30/24
-20.26 (-72.51%)
since 04/19/24

Most Recent Stories

More News
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

TXG : 7.68 (+2.26%)
PACB : 1.1400 (-2.56%)
HIMS : 25.84 (-5.10%)
MRNA : 25.13 (+1.68%)
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

TECH : 47.51 (-1.23%)
TXG : 7.68 (+2.26%)
PACB : 1.1400 (-2.56%)
BRKR : 35.98 (-0.83%)
WAT : 316.23 (-1.49%)
2 Reasons to Sell TXG and 1 Stock to Buy Instead

2 Reasons to Sell TXG and 1 Stock to Buy Instead

MSFT : 359.12 (-2.35%)
TXG : 7.68 (+2.26%)
1 Stock Under $50 on Our Watchlist and 2 to Ignore

1 Stock Under $50 on Our Watchlist and 2 to Ignore

TXG : 7.68 (+2.26%)
SHYF : 7.13 (-3.52%)
CFLT : 20.40 (-3.55%)
Why 10x Genomics (TXG) Shares Are Falling Today

Why 10x Genomics (TXG) Shares Are Falling Today

TXG : 7.68 (+2.26%)
10x Genomics: Q4 Earnings Snapshot

10x Genomics: Q4 Earnings Snapshot

TXG : 7.68 (+2.26%)
10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations

10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations

TXG : 7.68 (+2.26%)
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

TECH : 47.51 (-1.23%)
TXG : 7.68 (+2.26%)
ILMN : 72.00 (+1.12%)
Tempus AI Stock Before Q4 Earnings: To Buy or Not to Buy?

Tempus AI, Inc. TEM is likely to report fourth-quarter fiscal 2024 results shortly.See the Zacks Earnings Calendar to stay ahead of market-making news.For the fourth quarter and full-year 2024, Tempus...

TXG : 7.68 (+2.26%)
SOPH : 2.78 (-1.77%)
TEM : 40.98 (+1.31%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The aggressive growth fund investor has slowed her shopper this holiday season, but she still made time to build up some of her existing positions.

TXG : 7.68 (+2.26%)
GTLB : 40.97 (-4.50%)
AMZN : 167.32 (-3.06%)

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 8.29
2nd Resistance Point 7.99
1st Resistance Point 7.84
Last Price 7.68
1st Support Level 7.39
2nd Support Level 7.09
3rd Support Level 6.94

See More

52-Week High 29.37
Fibonacci 61.8% 20.74
Fibonacci 50% 18.08
Fibonacci 38.2% 15.41
Last Price 7.68
52-Week Low 6.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro